Single dose treatment of intestinal nematodes with oxantel-pyrantel pamoate plus mebendazole.
D000293:Adolescent; D000328:Adult; D000969:Antinematodal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001196:Ascariasis / Q000188:drug therapy; D001562:Benzimidazoles / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004334:Drug Administration Schedule; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy*; D008297:Male; D008463:Mebendazole / Q000008:administration & dosage / Q000627:therapeutic use*; D009332:Necatoriasis / Q000188:drug therapy; D009349:Nematode Infections / Q000188:drug therapy*; D011715:Pyrantel / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011716:Pyrantel Pamoate / Q000008:administration & dosage / Q000627:therapeutic use*; D014257:Trichuriasis / Q000188:drug therapy
D000969:Antinematodal Agents; D001562:Benzimidazoles; D004338:Drug Combinations; D011715:Pyrantel; D011716:Pyrantel Pamoate; D008463:Mebendazole; C003407:oxantel